chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe painful swelling in joints (hands, wrists, knees, shoulders, elbows)  still ongoing.  Severe painful muscles (legs, buttocks, lower back) still ongoing. Trouble sitting,  pain in buttocks while sitting, pain in standing from sitting. Once standing, difficulty straightening back and legs to upright position.  PCP prescribed anti-inflammatory.  Some relief. PCP prescribed steroids-good relief but couldn?t stay on steroids because of diabetes.  Still experiencing severe painful swelling of hands, wrist and knees as well as muscle pain in legs.
Sever chills, head ache, ear pressure, lock jaw, muscle soreness and tension, restlessness and extreme exhaustion, mouth sores making hard to eat
Hives/ Hives appear in different areas of body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives/ Hives appear in different areas of body) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced URTICARIA (Hives/ Hives appear in different areas of body). At the time of the report, URTICARIA (Hives/ Hives appear in different areas of body) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Updated reported term of event Hives. Patient continued to have issues with hives. NNI.
This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04May2021 at 15:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included type one diabetes - diagnosed at the age of 22 months. The patient was allergic to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included insulin (MANUFACTURER UNKNOWN), taken for type one diabetes from on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 at 15:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 01:00, the patient experienced fever, chills, body aches, headache, muscle aches and arm soreness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, body aches, headache, muscle aches and arm soreness was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Within hours of receiving vaccine, the patient experienced dizzyness, weakness, and muscle aches. The next day symptoms had worsened. Within 48 hours of receiving the vaccine, the patient experienced cardiac arrest requiring CPR.
Got pneumovax 23 in right deltoid muscle, I was expecting soreness around muscle but I experienced moderate pain in my R deltoid platysma/sternocleidomasroid muscles. Pain was persistent and lasted about 4-5 days post vaccination. I thought this was an odd site for referred pain.
12NOV92 tc from pt had flu vax on 6NOV92, onset of migraine type had 6NOV92 PM w/nausea & vomiting lasted approx 24 hrs; was in bed 7NOV & 8NOV D/T lethargy; c/o lethragy & some dizziness;
(R) arm edema, warmth, severe pain radiates to (R) neck and chest wall (shoulder to elbow), chills, dyspnea (had bilat upper lobe wheezing). Tx - MEDROL dose pack 11/9/10, albuterol inhaler.
a hard area feels rough to the touch/feels like something hard and bumpy under skin; Iches; its a hard area itches and a little warn to touch; Had a small sore place afterward; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (a hard area feels rough to the touch/feels like something hard and bumpy under skin), PRURITUS (Iches), FEELING HOT (its a hard area itches and a little warn to touch) and VACCINATION SITE PAIN (Had a small sore place afterward) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INDURATION (a hard area feels rough to the touch/feels like something hard and bumpy under skin), PRURITUS (Iches), FEELING HOT (its a hard area itches and a little warn to touch) and VACCINATION SITE PAIN (Had a small sore place afterward). At the time of the report, INDURATION (a hard area feels rough to the touch/feels like something hard and bumpy under skin), PRURITUS (Iches), FEELING HOT (its a hard area itches and a little warn to touch) and VACCINATION SITE PAIN (Had a small sore place afterward) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
About an hour after I discovered a red bumpy Rash on my stomach and breast. No pain or itching with it.  I have pictures of it if needed please feel free to email me.
The initial case was missing the following minimum criteria: ICH-Unspecified AE. Upon receipt of follow-up information on 21Nov2014, this case now contains all required information to be considered valid. This is a spontaneous report from a non-clinical study program. A contactable 84-year-old female consumer reported that she received PREVNAR 13 single dose, on 15Oct2014. The patient had a soy allergy. The patient experienced on 18Oct2014 pain in stomach, burning in lungs, lightheadedness, could not sleep in her bed, extreme cold, passed out trying to get up. The patient recovered from all adverse events on 15Nov2014. The consumer stated she was extremely allergic to soy and that was not told to her that it was a component.
Pt was administered a 2nd dose of moderna that was expired passed the 30 days, informed pt about incident, pt reports having sx of headache,body pain, pain in arm that vaccine was administerd, and fatigue.  Phone appointment was made with pts PCP to discuss sx
This spontaneous prospective pregnancy report was received from a licensed practical nurse refers to a female patient of unknown age who was pregnant at the moment of this report. The patient's medical history and concurrent condition were not reported. On an unspecified dates in March 2015 and May 2015, the patient was vaccinated with the first and second dose of GARDASIL (strength, dose, anatomical location, route of administration, lot # and expiration date were not reported). On 15-SEP-2015, the patient with 7 weeks of gestation (LMP approximately 28-JUL-2015) was vaccinated with GARDASIL 9 injection, 0.5 ml, intramuscular, lot # K026246, expiration date on 28-JAN-2017 (strength and anatomical location were not reported), as the third dose in the vaccination series. At the time of the report, pregnancy outcome and the fetal outcome were unknown. This case is one of two cases from the same patient (MARRS # 1509USA012555). Additional information has been requested.
Information has been received from a consumer for the Pregnancy Registry for GARDASIL vaccine (yeast) concerning herself, a 21 year old female, who in November 2007, was vaccinated with her third dose of GARDASIL vaccine (yeast) (lot # unspecified) and realized she was pregnant. Dates and lot numbers of the previous 2 doses were not reported. There was no concomitant medication. Unspecified medical attention was sought. Approximately in April 2008 the 7th month sonogram was performed (date not reported), and the physician noticed that the baby had an echogenic bowel. After this was found, on unspecified date the patient had amincentesis performed and the results were reported as "everything was normal". The patient reported that at the time of this report she was 34 weeks pregnant (estimated LMP is 17-Oct-2007). No further information was provided. No further information is available.
Flue like symptoms that lasted about eight days. A increase in fibromyalgia  five fold. that  finally abated  some what at the end of September 2021. On a scale of 0-10 I usually at four, Was running at seven. A normal person is at one. Seven is intense and not sustainable.  I believe getting vaccinated , Never had a reaction to flue vaccines before.   No income and trying to get back to
Pain at site of injection with shooting pains throughout the arm and spasms on the underside of same arm. No treatment for these symptoms at this time. Pain continue occasionally throughout arm radiating into neck at 22 days post injection. Advised to visit clients doctor.
ACHINESS; HEMATOMA AT INJECTION SITE; JOINT PAIN; CHILLS; FATIGUE; LOW GRADE FEVER; This spontaneous report received from a patient concerned an 82 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, and expiry: 23-AUG-2021) dose was not reported, administered on 04-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 04-MAR-2021, the patient experienced achiness. On 04-MAR-2021, the patient experienced hematoma at injection site. On 04-MAR-2021, the patient experienced joint pain. On 04-MAR-2021, the patient experienced chills. On 04-MAR-2021, the patient experienced fatigue. On 04-MAR-2021, the patient experienced low grade fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from achiness, joint pain, chills, fatigue, and low grade fever on 06-MAR-2021, and hematoma at injection site on 25-MAR-2021. This report was non-serious.
ACUTE DVT OF LEFT ILIAC VEIN 7/29/2022 ANEMIA DUE TO BLOOD LOSS HYPOTENSION 7/29/2022 ANEMIA DUE TO BLOOD LOSS
hearing loss.  started in right ear as ringing in ear now it has progress to significant hearing loss. i have been having ringing and hearing loss in the left ear as well.
Initial information received on 11-Oct-2018 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 1 years old female patient for whom received a PENTACEL vaccine that was expired was reported, while she received vaccine PENTACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Hepatitis B Vaccine for Immunisation; PREVNAR 13 for Immunisation; and FLUZONE QUADRIVALENT 0.5 ml for Immunisation. On 10-Oct-2018, the patient received a 0.5 ml standard dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine, lot C5230AA expiry date 02-Sep-2018 via unknown route in the right thigh. The patient developed a non-serious received a PENTACEL vaccine that was expired (expired product administered) unknown latency following the administration of Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine. Lab data not reported. The case is actual medication error due to expired vaccine used. Final diagnosis was received a PENTACEL vaccine that was expired. It was unknown whether patient experienced any adverse reaction after vaccination. Outcome of the event was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
Patient Diagnosed with COVID and admitted tot he hospital after receiving vaccine.  Symptoms -difficulty breathing , wheezing and cough
Bilateral diffuse hand effusions.  No known injury.  ROM impacted.  Autoimmune workup pending.
My first 3 doses were Moderna and my 4th dose was Pfizer. Starting 05/11/2022, I had a sore throat, hoarseness, sinus congestion, chest congestion and fever. The fever went away and then I was tested and it was positive for COVID. So, I did a telehealth visit with my doctor and she prescribed Paxlovid. I felt really good for 2 days and now I am having head congestion again and some slight dizziness.
Started crying x 2 days. Fever, rash covering body, diarrhea and not eating for 12 hours.
1/3/08 Stinging pain during injections at site only (no radiation, no N/T). 2 days post vaccine, increased amt of pain only at injection site> pain continues with rest and ibuprofen. Pain will worsen with arm movement. Pain seems to be lessen as the time goes on and has stopped until recently. Pt received 2nd injection with problems.
Late in the day on 8/31/22, the FDA rescinded the EUA order for the use of the monovalent Pfizer and Moderna vaccine as boosters for people aged 12 years and older. The information took a little time to trickle from the Government to local staff and then to our clinic and the staff administering vaccine. Because of this delay, some monovalent vaccine throughout the HCF was inadvertently given after 8/31/22. The CDC stated that any monovalent vaccine administered as a booster dose after the EUA was rescinded would be considered a vaccine error. At a recent Immunization Subcommittee meeting, we discussed this and our medical providers stated that any monovalent vaccine given as a booster dose on 9/1/2022 or after should have VAERS report completed on them per the CDC's requirements.
patient received an expired dose of Pediarix on 23Jun2021./expired on 14Jun2021; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 2-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number D93B4, expiry date 14th June 2021) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 23rd June 2021, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On 23rd June 2021, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The reporter reported that a patient received an expired dose of Pediarix on 23rd June 2021 which was already expired on 14th June 2021. No symptoms reported. The reporter consented to follow up.
Mild hives all over body(arms,legs,stomach,back). No redness, irritation, scratching.
PATIENTS MOTHER CALLED APPROX 1 HOUR AFTER VACCINE GIVEN.  PATIENT DEVELOPED A RASH ALL OVER TRUNK OF BODY APPROX 45 MINUTES AFTER VACCINE GIVEN.  PATIENT WAS GIVEN 50MG BENADRYL.
I experienced extremely elevated blood pressure, at stoke level. It was stubborn, had to increase my hypertension medication. BP finally decreased from a dangerous level to a high, but no longer dangerous one. I remained on that increased treatment until the second vaccine dose was given. BP was high the entire period, it remained elevated for at least a month following the second shot.  I felt terrible during those few weeks, experienced headaches that would not go away. Had to take a CT scan of the head to be certain that there wasn?t bleeding in the brain, and that I actually didn?t have a stroke. I am still on the same medication regimen. Spent several hours at the clinic to ensure that there wasn?t any danger before going home.
Information has been received from a consumer referring to her daughter. In FEB-2006, at the same office visit 9 years ago, the patient was vaccinated with LIQUID PEDVAXHIB (lot #, expiration date, dose and route unspecified)0, DTaP (lot #, expiration date, dose and route unspecified) and PREVNAR (lot #, expiration date, dose and route unspecified). On an unknown date the patient developed high fever of three days as well as tremors that lasted for four months. The outcome of events was unknown. Additional information has been requested.
Information has been received from a physician concerning a female who "two weeks ago" on approximately 04-SEP-2008 was vaccinated with her second dose of GARDASIL. There was no concomitant medication. Subsequently, the patient has continuing pain in her arm. The physician reported that the patient has been able to continue to work. The patient did not experience any problems after the first dose (date of administration not known). The patient has been taking MOTRIN for the discomfort results were not known. The patient's pain in her arm persisted. The patient has an appointment to see the physician on 22-SEP-2008. Additional information has been requested.
50-year-old female presents complaining of cough and chest pain while coughing. Vital signs stable on arrival. Patient is not hypoxic. Labs reviewed, no significant abnormalities. Patient also positive for Covid. Chest x-ray shows no acute process. Patient's chest pain improved with Toradol, Robaxin, Zofran, and Tessalon Perles. Patient will be given a prescription for Motrin and steroids for home. She'll also be given a referral for the infusion clinic. Patient made aware. She was also given a pulse ox for home and strict return precautions.
Hospitalized 5/10/22-5/13/22 sore throat, cough, fever, chills, PNA, decreased appetite,
itching all over body. Patient has had similar reaction to injectable medications in the past. Benadryl administered.
Has approx 2.5" to 3" red area on left thigh.Fosterparents notice this Saturday.They will report this to her doctor.
Daughter received a double dose of H1N1 vaccine.  She was supposed to receive 0.25ml of multidose vial and received 0.5ml of multi-dose vial.
Inbound call from Merck FBE who reports potential MMR-II adverse event. While speaking with a pharmacist she states he mentioned they had a 12 month old patient with immunodeficiency who received an MMR vaccine who was not supposed to receive a live; Infant had fever for a week and they were considering measles infection; This spontaneous report was received from a pharmacist and refers to a 12 month old patient of unknown gender. The patient's concurrent conditions included immunodeficiency. The patient's medical history, concomitant medications , drug reactions or allergies were not reported.   On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot #, expiration date, dose, route of administration, anatomical location not provided) as prophylaxis; which was not supposed to receive it due to the patient's immunodeficiency (product use in unapproved indication).  On an unknown date in July 2023 (between 9th and 15th), the patient experienced fever for a week; therefore, they were considering measles infection due to vaccination, but in the end it was determined as a diagnosis of fever. At the reporting time, the outcome of the fever was unknown.   Causality assessment between fever and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II) was not reported.
Ringing in left ear; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 06Apr2021 at 09:15 (at the age of 36-year-old), as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. Patient has known allergy to sulfa meds. Concomitant medications included topiramate (TOPAMAX), buspirone hydrochloride (BUSPAR) and iron supplements (IRON) all for unknown indication from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 16:00, the patient experienced ringing in left ear. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event ringing in left ear was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Daily Headaches, Felt like tight knot in epigastric area, weakness, high blood pressure, heart palpitations, high heart rate, overcome by feeling like was going to die(only in the first 3 weeks), lost 8 pounds in 2 weeks,  feeling of heavy arms and legs,  sensitive to caffeine and sugar  First month was the worst and slowly started feeling some better.  Still have headaches, blood pressure problems, palpitations, uncomfortable feeling in epigastric region and sometimes feels tight there like its being squeezed, dont have much stamina, cant exercise (was a runner)